Quansys Biosciences

Executive Summary

Quansys Biosciences is a privately-held biotechnology company based in Logan, Utah, founded in 2005. The company specializes in the development and manufacture of multiplex ELISA kits and imaging systems, primarily for research use. Its core Q-Plex™ technology allows simultaneous quantitative measurement of up to 18 biomarkers from a single sample, offering researchers cost-effective and high-quality data. This technology is particularly valuable in fields such as immunology, oncology, and infectious disease research, where multi-analyte profiling can accelerate discoveries. Quansys products are used across academic, biopharma, and contract research organization (CRO) laboratories, providing a competitive alternative to traditional single-plex assays and more expensive multiplex platforms. The company operates as a niche player in the diagnostics and antibodies categories, with a focus on expanding its product portfolio and market reach.

Upcoming Catalysts (preview)

• Q3 2026Launch of extended Q-Plex panel covering 25+ biomarkers70% success
• Q4 2026Partnership with a major pharmaceutical company for preclinical biomarker analysis50% success
• TBDFDA 510(k) clearance for a diagnostic-use multiplex assay30% success